Literature DB >> 6607731

Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone.

P A Price, M R Urist, Y Otawara.   

Abstract

A new protein has been isolated from CaCl2/urea extracts of demineralized bovine bone matrix. This protein has five to six residues of the vitamin K-dependent amino acid, gamma-carboxyglutamic acid (Gla), and we have accordingly designated it matrix Gla protein. Matrix Gla protein is a 15,000 dalton protein whose amino acid composition includes a single disulfide bond. The absence of 4-hydroxyproline in matrix Gla protein demonstrates that it is not a precursor to bone Gla protein, 5,800 dalton protein which has a residue of 4-hydroxyproline at position 9 in its sequence. Matrix Gla protein also does not cross-react with antibodies raised against bone Gla protein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6607731     DOI: 10.1016/0006-291x(83)91663-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  78 in total

1.  Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues.

Authors:  J D Kulman; J E Harris; L Xie; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

2.  Total chemical synthesis of human matrix Gla protein.

Authors:  T M Hackeng; J Rosing; H M Spronk; C Vermeer
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

3.  Production of monoclonal antibodies specific for human bone gamma-carboxyglutamic acid containing protein.

Authors:  T Ohta; M Mori; H Koshiba; J Takada; T Matsuyama; S Ishii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Cloning of matrix Gla protein in a marine cartilaginous fish, Prionace glauca: preferential protein accumulation in skeletal and vascular systems.

Authors:  J B Ortiz-Delgado; D C Simes; C S B Viegas; B J Schaff; C Sarasquete; M L Cancela
Journal:  Histochem Cell Biol       Date:  2006-01-13       Impact factor: 4.304

5.  Basic fibroblast growth factor as a selective inducer of matrix Gla protein gene expression in proliferative chondrocytes.

Authors:  Chantal Stheneur; Marie-France Dumontier; Claudie Guedes; Marie-Claude Fulchignoni-Lataud; Khadija Tahiri; Gerard Karsenty; Marie Thérèse Corvol
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

6.  Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification.

Authors:  D Tuñón-Le Poultel; J B Cannata-Andía; P Román-García; J B Díaz-López; E Coto; C Gómez; M Naves-Díaz; I Rodríguez
Journal:  Osteoporos Int       Date:  2013-11-27       Impact factor: 4.507

7.  Articular-cartilage matrix gamma-carboxyglutamic acid-containing protein. Characterization and immunolocalization.

Authors:  R Loeser; C S Carlson; H Tulli; W G Jerome; L Miller; R Wallin
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.

Authors:  Minoru Takagi; Naoko Kamiya; Tomihisa Takahashi; Shinsuke Ito; Mitsuharu Hasegawa; Naoto Suzuki; Koji Nakanishi
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

9.  Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography.

Authors:  M R Urist; Y K Huo; A G Brownell; W M Hohl; J Buyske; A Lietze; P Tempst; M Hunkapiller; R J DeLange
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Circulating calcification inhibitors and vascular properties in children after renal transplantation.

Authors:  Marieke J H van Summeren; Jeroen M Hameleers; Leon J Schurgers; Arnold P G Hoeks; Cuno S P M Uiterwaal; Thilo Krüger; Cees Vermeer; Wietse Kuis; Marc R Lilien
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.